AAAAAA

   
Results: 1-14 |
Results: 14
A EBMT SURVEY OF 65 CASES TRANSPLANTED FOR T-CELL AND NULL-CELL TYPE CD30 POSITIVE ANAPLASTIC LARGE-CELL LYMPHOMA
Authors: FANIN R SILVESTRI F DEELVIRA MCR TAGHIPOUR G SPEROTTO A GOLDSTONE AH
Citation: R. Fanin et al., A EBMT SURVEY OF 65 CASES TRANSPLANTED FOR T-CELL AND NULL-CELL TYPE CD30 POSITIVE ANAPLASTIC LARGE-CELL LYMPHOMA, Bone marrow transplantation, 21, 1998, pp. 584-584
THE NUMBER OF RED-CELL TRANSFUSION INCREASES SIGNIFICANTLY AS THE PLATELET COUNT DROPS BELOW 25
Authors: KOTTARIDIS PD DEELVIRA MCR PATTERSON K DEVEREUX S
Citation: Pd. Kottaridis et al., THE NUMBER OF RED-CELL TRANSFUSION INCREASES SIGNIFICANTLY AS THE PLATELET COUNT DROPS BELOW 25, British Journal of Haematology, 101, 1998, pp. 317-317
5-DAY ORAL ETOPOSIDE TREATMENT FOR ADVANCED SMALL-CELL LUNG-CANCER - RANDOMIZED COMPARISON WITH INTRAVENOUS CHEMOTHERAPY
Authors: SOUHAMI RL SPIRO SG RUDD RM DEELVIRA MCR JAMES LE GOWER NH LAMONT A HARPER PG
Citation: Rl. Souhami et al., 5-DAY ORAL ETOPOSIDE TREATMENT FOR ADVANCED SMALL-CELL LUNG-CANCER - RANDOMIZED COMPARISON WITH INTRAVENOUS CHEMOTHERAPY, Journal of the National Cancer Institute, 89(8), 1997, pp. 577-580
OUTCOME OF ADVANCED EPITHELIAL OVARIAN-CANCER IN WOMEN UNDER 40 YEARS
Authors: DEMIRANDA MP LEDERMANN JA DEELVIRA MCR NELSTROP A LAMBERT HA RUSTIN GJS TRASK CJ SOUHAMI RL
Citation: Mp. Demiranda et al., OUTCOME OF ADVANCED EPITHELIAL OVARIAN-CANCER IN WOMEN UNDER 40 YEARS, European journal of cancer, 33, 1997, pp. 526-526
ADJUVANT CHEMOTHERAPY FOR LOCALIZED RESECTABLE SOFT-TISSUE SARCOMA OFADULTS - METAANALYSIS OF INDIVIDUAL DATA
Authors: TIERNEY JF STEWART LA PARMAR MKB FLETCHER CDM JONES G MOSSERI V PATEL M DEELVIRA MCR SOUHAMI RL SYLVESTER R TURSZ T ALVEGARD TA SIGURDSSON H ANTMAN K BACCHI M BAKER LH BENJAMIN RS BRADY MF BRAMWELL V BUI BN EDMONSON JH LEYVRAZ S OMURA GA ROUESSE J RYAN L VANOOSTEROM AT YANG JC
Citation: Jf. Tierney et al., ADJUVANT CHEMOTHERAPY FOR LOCALIZED RESECTABLE SOFT-TISSUE SARCOMA OFADULTS - METAANALYSIS OF INDIVIDUAL DATA, Lancet, 350(9092), 1997, pp. 1647-1654
THE LENGTH OF THE FIRST COMPLETE REMISSION (1-6 MONTHS, 7-12 MONTHS GREATER-THAN-12 MONTHS) DOES NOT PREDICT OUTCOME FOLLOWING BEAM AND AUTOTRANSPLANTATION FOR HODGKINS-DISEASE IN FIRST RELAPSE
Authors: KOTTARIDIS PD PENIKET AJ PERRY AR HARRISON CN DEELVIRA MCR MACMILLAN A DEVEREUX S LINCH DC GOLDSTONE AH
Citation: Pd. Kottaridis et al., THE LENGTH OF THE FIRST COMPLETE REMISSION (1-6 MONTHS, 7-12 MONTHS GREATER-THAN-12 MONTHS) DOES NOT PREDICT OUTCOME FOLLOWING BEAM AND AUTOTRANSPLANTATION FOR HODGKINS-DISEASE IN FIRST RELAPSE, Blood, 90(10), 1997, pp. 496-496
OUTCOME OF BEAM AUTOTRANSPLANTATION IN PATIENTS WITH HODGKINS-DISEASEPROGRESSING ON FIRST LINE THERAPY IS THE SAME AS IN PATIENTS TRANSPLANTED IN FIRST PARTIAL REMISSION
Authors: PENIKET AJ KOTTARIDIS PD PERRY AR DEELVIRA MCR DEVEREUX S MACMILLAN A GOLDSTONE AH LINCH DC
Citation: Aj. Peniket et al., OUTCOME OF BEAM AUTOTRANSPLANTATION IN PATIENTS WITH HODGKINS-DISEASEPROGRESSING ON FIRST LINE THERAPY IS THE SAME AS IN PATIENTS TRANSPLANTED IN FIRST PARTIAL REMISSION, Blood, 90(10), 1997, pp. 497-497
AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR T-CELL AND NULL-CELL TYPES CD-30 POSITIVE ANAPLASTIC LARGE-CELL LYMPHOMA - PRELIMINARY-ANALYSIS OF65 CASES REPORTED TO THE EBMT
Authors: FAMIN R SILVESTRI F DEELVIRA MCR TAGHIPOUR G SPEROTTO A GOLDSTONE AH
Citation: R. Famin et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR T-CELL AND NULL-CELL TYPES CD-30 POSITIVE ANAPLASTIC LARGE-CELL LYMPHOMA - PRELIMINARY-ANALYSIS OF65 CASES REPORTED TO THE EBMT, Blood, 90(10), 1997, pp. 1021-1021
ALLOGENIC TRANSPLANTATION FOR LYMPHOMA PRODUCES A LOWER RELAPSE RATE THAN AUTOLOGOUS TRANSPLANTATION BUT SURVIVAL IS WORSE BECAUSE OF HIGHER TREATMENT RELATED MORTALITY - A REPORT OF 764 CASES FROM THE EBMT LYMPHOMA REGISTRY
Authors: PENIKET AJ DEELVIRA MCR TAGHIPOUR G DEWITTE T TAZELAAR PJ CARELLA A VERNANT JP SCHAEFER UW CLEEVEN M BOOGAERTS MA GLUCKMAN E GOLDSTONE AH
Citation: Aj. Peniket et al., ALLOGENIC TRANSPLANTATION FOR LYMPHOMA PRODUCES A LOWER RELAPSE RATE THAN AUTOLOGOUS TRANSPLANTATION BUT SURVIVAL IS WORSE BECAUSE OF HIGHER TREATMENT RELATED MORTALITY - A REPORT OF 764 CASES FROM THE EBMT LYMPHOMA REGISTRY, Blood, 90(10), 1997, pp. 1121-1121
A RANDOMIZED STUDY OF ORAL ETOPOSIDE VERSUS COMBINATION CHEMOTHERAPY IN POOR-PROGNOSIS SMALL-CELL LUNG-CANCER
Authors: HARPER P UNDERHILL C DEELVIRA MCR RUDD R SOUHAMI R SPIRO S TRASK C PARTRIDGE M TOBIAS J LEDERMANN J ERAUT D JAMES L
Citation: P. Harper et al., A RANDOMIZED STUDY OF ORAL ETOPOSIDE VERSUS COMBINATION CHEMOTHERAPY IN POOR-PROGNOSIS SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 14(5), 1996, pp. 2019-2019
A RANDOMIZED TRIAL OF LOW-DOSE HIGH-FREQUENCY CHEMOTHERAPY AS PALLIATIVE TREATMENT OF POOR-PROGNOSIS SMALL-CELL LUNG-CANCER - A CANCER-RESEARCH CAMPAIGN TRIAL/
Authors: JAMES LE GOWER NH RUDD RM SPIRO SG HARPER PG TRASK CW PATRIDGE M DEELVIRA MCR SOUHAMI RL
Citation: Le. James et al., A RANDOMIZED TRIAL OF LOW-DOSE HIGH-FREQUENCY CHEMOTHERAPY AS PALLIATIVE TREATMENT OF POOR-PROGNOSIS SMALL-CELL LUNG-CANCER - A CANCER-RESEARCH CAMPAIGN TRIAL/, British Journal of Cancer, 73(12), 1996, pp. 1563-1568
ASSESSMENT OF QUALITY-OF-LIFE USING A DAILY DIARY CARD IN A RANDOMIZED TRIAL OF CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER
Authors: GOWER NH RUDD RM DEELVIRA MCR SPIRO SG JAMES LE HARPER PG SOUHAMI RL
Citation: Nh. Gower et al., ASSESSMENT OF QUALITY-OF-LIFE USING A DAILY DIARY CARD IN A RANDOMIZED TRIAL OF CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER, Annals of oncology, 6(6), 1995, pp. 575-580
RANDOMIZED TRIAL COMPARING WEEKLY VERSUS 3-WEEK CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - A CANCER-RESEARCH CAMPAIGN TRIAL
Authors: SOUHAMI RL RUDD R DEELVIRA MCR JAMES L GOWER N HARPER PG TOBIAS JS PARTRIDGE MR DAVISON AG TRASK C SPIRO SG
Citation: Rl. Souhami et al., RANDOMIZED TRIAL COMPARING WEEKLY VERSUS 3-WEEK CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - A CANCER-RESEARCH CAMPAIGN TRIAL, Journal of clinical oncology, 12(9), 1994, pp. 1806-1813
CHEMOTHERAPY DOSE INTENSITY IN SMALL-CELL LUNG-CANCER
Authors: SOUHAMI RL DEELVIRA MCR
Citation: Rl. Souhami et Mcr. Deelvira, CHEMOTHERAPY DOSE INTENSITY IN SMALL-CELL LUNG-CANCER, Lung cancer, 10, 1994, pp. 190000175-190000185
Risultati: 1-14 |